SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-24-024548
Filing Date
2024-06-20
Accepted
2024-06-20 17:20:15
Documents
13
Period of Report
2024-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 57588
  Complete submission text file 0001493152-24-024548.txt   236902

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mymd-20240520.xsd EX-101.SCH 3003
3 XBRL LABEL FILE mymd-20240520_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE mymd-20240520_pre.xml EX-101.PRE 22351
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3814
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36268 | Film No.: 241057497
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)